References
- Schwartz LM, Halloran ME, Durbin AP, et al. The dengue vaccine pipeline: Implications for the future of dengue control. Vaccine. 2015;33:3293–3298.
- World Health Organization. Dengue and severe dengue. Fact sheet N°117. [ cited 2015 Aug 12]. Available from: http://www.who.int/mediacentre/factsheets/fs117/en
- Johns Hopkins University. Bloomberg School of Public Health. IVAC Blog. Laying the Groundwork for Countries in the Americas: A Viable Plan for Dengue Vaccine Introduction. [ cited 2015 Aug 10]. Available from: http://www.jhsph.edu/research/centers-and-institutes/ivac/IVACBlog/keyword/dengue
- Capeding MR, Tran NH, Hadinegoro SR, et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet. 2014;384(9951):1358–1365.
- Villar L, Dayan GH, Arredondo-García JL, et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. New England J Med. 2015;372(2):113–123.
- Reuters. Buzz Off: New Survey Finds Americans Underestimate the Presence of Mosquito-Related Disease in U.S. [ cited 2015 Aug 10]. Available from: http://www.reuters.com/article/2015/08/10/va-npma-idUSnBw105999a+100+BSW20150810
- The Economist. Dengue in India: The billion-dollar disease. [ cited 2015 Aug 10]. Available from: http://www.economist.com/blogs/banyan/2014/10/dengue-india
- Douglas DL, DeRoeck DA, Mahoney RT, et al. Will dengue vaccines be used in the public sector and if so, how? Findings from an 8-country survey of policymakers and opinion leaders. PLoS Negl Trop Dis. 2013;7(3):e2127.
- Ferraz LMR, Gomes IMDAM. Construction of the discourse on dengue fever in the media. Revista Brasileira De Epidemiologia. 2012;15(1):63–74.
- Pediatric Dengue Vaccine Initiative. Dengue Communication. Seoul: International Vaccine Institute; 2010.
- San Martín JL, Brathwaite O. La Estrategia de Gestión Integrada para la Prevención y el Control del Dengue en la Región de las Américas. Rev Panam Salud Pública/Pan Am J Public Health. 2007;21:56–57.
- World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention, and control. New ed. Geneva: WHO; 2009.
- Parks W, Llyod L. Planning social mobilization and communication for dengue prevention and control: A step-by-step guide. Geneva: WHO; 2004.
- World Health Organization. Global strategy for dengue prevention and control 2012-2020. Geneva: WHO; 2012.
- Dengue Vaccine Initiative. Points for Consideration. Meeting of potential first-to-introduce countries of dengue vaccines. [ cited 2015 July 30]. Available from: http://www.denguevaccines.org/sites/default/files/files/Day%201_3_PFC_RMahoney.pdf. [ cited 2015 August 14]. Available from: http://www.denguevaccines.org/sites/default/files/Dengue%20Communications_Medellin_1.pdf
- Waisbord S, Larson H. Why invest in communication for immunization: evidence and lessons learned. New York, NY: United Nations Children’s Fund; 2005.
- World Health Organization. World health day 2014: preventing vector-borne diseases. [ cited 2015 Aug 13]. Available from: http://www.who.int/mediacentre/news/releases/2014/small-bite-big-threat/en/
- World Health Organization. World health day - 7 april 2014. [ cited 2015 Aug 13]. Available from: http://www.who.int/campaigns/world-health-day/2014/event/en/
- Pan American Health Organization/World Health Organization. State of the art in prevention and control of dengue in the Americas. [ cited 2015 Aug 10]. Available from: http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=25890&Itemid=
- Deane J, Parks W. Advocacy communication and social mobilization to fight TB: a 10-year framework for action. ACSM, subgroup at county level. Geneva: WHO Stop TB Partnership; 2006.
- Pappaioanou M, Malison M, Wilkins K, et al. Strengthening capacity in developing countries for evidence-based public health: the data for decision-making project. Soc Sci Med. 2003;57(10):1925–1937.
- Levine OS, Hajjeh R, Wecker J, et al. A policy framework for accelerating adoption of new vaccines. Hum Vaccin. 2010;6(12):1021–1024.
- World Health Organization. Vaccine introduction guidelines: Adding a vaccine to a national immunization program: decision and implementation. Document No. WHO/IVB/05.18. Geneva: WHO (2005).
- Bandura A. Health promotion by social cognitive means. Health Educ Behav. 2004;31(2):143–164.
- Pelletier LG, Sharp E. Persuasive communication and proenvironmental behaviours: How message tailoring and message framing can improve the integration of behaviours through self-determined motivation. Canadian Psychology/Psychologie Canadienne. 2008;49(3):210–217.
- The Guardian. Preparing for a dengue fever vaccine: why Brazil’s ahead of the game. [ cited 2015 Sep 18]. Available from: http://www.theguardian.com/global-development-professionals-network/2014/jan/27/dengue-fever-vaccine-development-brazil
- Schmitz J, Roehrig J, Barrett A, et al. Next generation dengue vaccines: a review of candidates in preclinical development. Vaccine. 2011;29(42):7276–7284.
- Hadinegoro SR, Arredondo-García JL, Capeding MR, et al. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. New England J Med. 2015;373(13):1195–1206.
- Deutsche Bank Markets Research. Tropical diseases; social responsibility, neglected market. London: Deutsche Bank AG; 2014.
- Dengue Vaccine Initiative. Report of the Americas dengue prevention board meeting. Bogota, Colombia: Development of Dengue Vaccines: A Review of the Status and Future Considerations; 2015.
- Shiffman J. A social explanation for the rise and fall of global health issues. Bull World Health Organ. 2009;87.8:608–613.
- Tversky A, Kahneman D. Rational choice and the framing of decisions. J Business. 1986;59:S251–S278.